"TRAF6 is a signal transducer that activates IkappaB kinase (IKK) and Jun amino-terminal kinase (JNK) in response to pro-inflammatory mediators such as interleukin-1 (IL-1) and lipopolysaccharides (LPS)."

"This Ubc complex, together with TRAF6, catalyses the formation of a Lys 63 (K63)-linked polyubiquitin chain that mediates IKK activation through a unique proteasome-independent mechanism."

"TRAF6, a RING domain protein, functions together with Ubc13/Uev1A to catalyze the synthesis of unique polyubiquitin chains linked through lysine-63 (K63) of ubiquitin."

"Blockade of this polyubiquitin chain synthesis, but not inhibition of the proteasome, prevents the activation of IKK by TRAF6."

"Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation."

"**TRAF6 (TNF receptor-associated factor 6)** is a human TRAF-family cytosolic signaling adaptor that also functions as a **RING-type E3 ubiquitin ligase** (EC 2.3.2.27). Recent literature consistently describes a conserved multi-domain architecture with **N-terminal RING** and multiple **zinc fingers**, a **coiled-coil/TRAF-N** region, and a **C-terminal TRAF-C/MATH (TRAF) domain** responsible for receptor/adaptor binding"

"Functionally, TRAF6 is best understood as a **signal-proximal ubiquitin ligase/scaffold** that converts receptor stimulation into **polyubiquitin-based signaling scaffolds** which recruit and activate downstream kinases (e.g., TAK1 and IKK) to drive **NF-κB** and **MAPK** activation"

"TRAF6 catalyzes ubiquitin transfer in the canonical E1–E2–E3 cascade as an **E3 ligase**, promoting formation of polyubiquitin chains that serve primarily as **non-degradative signaling scaffolds**, rather than proteasomal degradation signals"

"The most consistently supported E2 complex for TRAF6 is **Ubc13/UBE2N–Uev1A/UBE2V1**, which is directly linked to TRAF6-mediated assembly of **K63-linked polyubiquitin chains**"

"Representative TRAF6-linked K63-modified signaling substrates/adaptors cited in 2024 review pages include **IKKγ/NEMO, TAK1, IRAK1, and TRAF6 itself**... The same review corpus notes that TRAF6 can participate in **K48-linked** ubiquitination in selected contexts, indicating that TRAF6 signaling can be coupled to regulated proteostasis depending on cellular conditions"

"Across recent primary studies, TRAF6 is described/observed as a **cytosolic adaptor** that associates with the **cytoplasmic tails of transmembrane receptors** and with inducible cytosolic signaling assemblies"

"**Receptor-proximal complexes (RANK):** TRAF6 binds receptor cytoplasmic domains such as **RANK** in RANKL signaling to coordinate downstream activation of MAPKs/AKT and NF-κB/NFATc1 programs that drive osteoclastogenesis"

"In response to ADP-heptose and other inflammatory stimuli, TRAF6 can form **cytosolic liquid-like condensates** (LLPS) with dynamic exchange properties (20–60% FRAP recovery in ~5 min), which are proposed to function as “microreactors” concentrating ubiquitin machinery and downstream effectors"

"A central, repeatedly cited role is TRAF6 in **TLR/IL-1 receptor family signaling**, where TRAF6 is recruited downstream of receptor-proximal adaptors/kinases to promote TAK1 and IKK activation, leading to NF-κB and MAPK transcriptional programs"

"TRAF6 is essential in **RANKL–RANK signaling**, acting as a key adaptor/E3 ligase required for osteoclastogenic downstream cascades (MAPK, PI3K/AKT, IκB phosphorylation) and NF-κB activation"

"A major 2024 development is the high-resolution demonstration that EBV **LMP1** uses a **direct TRAF6-binding motif** (CTAR2 region) to drive NF-κB/JNK/p38/IRF7 signaling and lymphoma cell survival... Importantly, structural/functional analyses indicate the **LMP1–TRAF6 interface differs from CD40–TRAF6**"

"Ayyasamy et al. (2024-07; https://doi.org/10.1016/j.jbc.2024.107487) show that **14-3-3ζ** binds TRAF6 (interaction increases rapidly after RANKL stimulation), reduces the **RANK–TRAF6 interaction**, and promotes **TRAF6 ubiquitination and proteasome-dependent degradation**, dampening downstream RANKL signaling"

"Li et al. (2024-01; https://doi.org/10.34133/research.0315) report that during ALPK1/TIFA-dependent sensing of bacterial ADP-heptose, TRAF6 undergoes stimulus-dependent **LLPS** and is recruited into **TIFA condensates**. Within these condensates, TRAF6 markedly amplifies **K63-linked polyubiquitin synthesis** when reconstituted with E1 and the **Ubc13/Uev1A** E2 complex"

"TRAF6 signaling output is not only determined by enzyme identity (E2 pairing and linkage type), but also by **higher-order mesoscale organization** (condensates that retain long K63 chains and concentrate enzymatic components)"

"Additional pathways in recent review/primary papers include **CD40/TRAF6-related signaling**, **IL-17R via Act1**, **TCR via CARMA1–BCL10–MALT1**, **TLR7/8/9–MYD88–IRF7**, and **ALPK1–TIFA–TRAF6** innate sensing"

"TRAF6 should be annotated as a **cytosolic receptor-proximal E3 ubiquitin ligase/adaptor** whose primary biochemical output is **Ubc13/Uev1A-dependent K63 polyubiquitin chain assembly**, enabling recruitment/activation of TAK1/IKK and MAPK modules to drive inflammatory and differentiation programs"

"Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6."

"We report the identification and characterization of a novel intermediate in these signaling pathways that bridges TRAF6 to MEKK-1."

"MUL and USP7 are capable of binding in vitro via their TDs to all of the previously identified TRAF family proteins (TRAF1, TRAF2, TRAF3, TRAF4, TRAF5, and TRAF6), whereas the TD of SPOP interacts weakly with TRAF1 and TRAF6 only."

"Analysis of various MUL and USP7 mutants by transient transfection assays indicated that the TDs of these proteins are necessary and sufficient for suppressing NF-kappaB induction by TRAF2 and TRAF6 as well as certain TRAF-binding TNF family receptors."

"TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway."

"IL-1 stimulates translocation of TAB2 from the membrane to the cytosol where it mediates the IL-1-dependent association of TAK1 with TRAF6."

"Coexpression of TRAF2 with p75(NTR) enhanced cell death, whereas coexpression of TRAF6 was cytoprotective."

"TRAF4 also inhibited the NF-kappaB response, whereas TRAF2 and TRAF6 enhanced p75(NTR)-induced NF-kappaB activation."

"We report the identification of a TRAF-interacting protein, T6BP, that specifically associates with TRAF6. This interaction occurs between the coiled-coil region of T6BP and the N-terminal ring finger and zinc finger domains of TRAF6."

"IL-1, but not tumor necrosis factor, induces TRAF6-T6BP complex formation in a ligand-dependent manner. Formation of the TRAF6-T6BP complex depends on the presence of the IL-1 receptor-associated kinase (IRAK)."

"When IRAK is phosphorylated in response to IL-1, it binds to the membrane where it forms a complex with TRAF6; TRAF6 then dissociates and translocates to the cytosol. The membrane-bound IRAK similarly mediates the IL-1-induced translocation of TAB2 from the membrane to the cytosol."

"The translocation of TAB2 and TRAF6 is needed to form a TRAF6-TAK1-TAB1-TAB2 complex in the cytosol and thus activate TAK1."

"The structural determinant of the petide TRAF6 interaction reveals a Pro-X-Glu-X-X-(aromatic/acidic residue) TRAF6-binding motif, which is present not only in CD40 and TRANCE-R but also in the three IRAK adapter kinases for IL-1R/TLR signalling."

"Tumour-necrosis factor (TNF) receptor-associated factor 6 (TRAF6) is the only TRAF family member that participates in signal transduction of both the TNF receptor (TNFR) superfamily and the interleukin-1 receptor (IL-1R)/Toll-like receptor (TLR) superfamily; it is important for adaptive immunity, innate immunity and bone homeostasis."

"mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6."

"TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-κB."

"By reconstituting TAK1 activation in vitro using purified proteins, here we show that free Lys 63 polyubiquitin chains, which are not conjugated to any target protein, directly activate TAK1 by binding to the ubiquitin receptor TAB2 (also known as MAP3K7IP2)."

"Furthermore, we found that unanchored polyubiquitin chains synthesized by TRAF6 and UBCH5C (also known as UBE2D3) activate the IKK complex."

"Here we show that the MAPKK kinase TAK1 acts upstream of NIK in the IL-1-activated signalling pathway and that TAK1 associates with TRAF6 during IL-1 signalling."

"Our results indicate that TAK1 links TRAF6 to the NIK-IKK cascade in the IL-1 signalling pathway."